Medtronic’s Aurora EV ICD system will be the first extravascular implantable cardioverter defibrillator available in the US.
On 23 October, the US Food and Drug Administration approved Aurora to provide defibrillation shocks, anti-tachycardia pacing (ATP), and...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?